CRISPR Therapeutics is a biotechnology company that leverages CRISPR-Cas9 gene-editing technology to develop curative therapies for genetic diseases, oncology, and regenerative medicine. Notable for its proprietary nuclease platform and strategic partnerships to advance both ex vivo and in vivo treatments, the company focuses on translating precise genome editing into clinically meaningful outcomes.
EN